Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elekta AB stock logo
EKTAY
Elekta
$5.56
+0.9%
$5.96
$4.35
$6.93
$2.03B11,935 shs1,890 shs
Glaukos Corporation stock logo
GKOS
Glaukos
$126.76
+2.0%
$124.00
$73.16
$148.11
$7.30B0.821.32 million shs707,972 shs
Sartorius stock logo
SARTF
Sartorius
$217.65
$218.06
$181.58
$227.00
$7.45B0.98225 shsN/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$8.74
-2.7%
$8.75
$8.12
$18.10
$5.65B1.1188,071 shs82,607 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elekta AB stock logo
EKTAY
Elekta
-1.81%-7.99%-10.51%-7.52%+5.25%
Glaukos Corporation stock logo
GKOS
Glaukos
+1.46%+2.11%-8.91%+28.27%+25.22%
Sartorius stock logo
SARTF
Sartorius
0.00%0.00%+2.50%-3.84%+8.80%
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
-0.44%-3.75%+9.90%+3.69%-46.17%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elekta AB stock logo
EKTAY
Elekta
$5.56
+0.9%
$5.96
$4.35
$6.93
$2.03B11,935 shs1,890 shs
Glaukos Corporation stock logo
GKOS
Glaukos
$126.76
+2.0%
$124.00
$73.16
$148.11
$7.30B0.821.32 million shs707,972 shs
Sartorius stock logo
SARTF
Sartorius
$217.65
$218.06
$181.58
$227.00
$7.45B0.98225 shsN/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$8.74
-2.7%
$8.75
$8.12
$18.10
$5.65B1.1188,071 shs82,607 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elekta AB stock logo
EKTAY
Elekta
-1.81%-7.99%-10.51%-7.52%+5.25%
Glaukos Corporation stock logo
GKOS
Glaukos
+1.46%+2.11%-8.91%+28.27%+25.22%
Sartorius stock logo
SARTF
Sartorius
0.00%0.00%+2.50%-3.84%+8.80%
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
-0.44%-3.75%+9.90%+3.69%-46.17%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elekta AB stock logo
EKTAY
Elekta
1.00
SellN/AN/A
Glaukos Corporation stock logo
GKOS
Glaukos
2.79
Moderate Buy$148.0016.76% Upside
Sartorius stock logo
SARTF
Sartorius
4.00
Strong BuyN/AN/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
2.33
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest EKTAY, SARTF, GKOS, and SSMXY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$140.00 ➝ $162.00
6/10/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Reiterated RatingBuy$162.00
6/2/2026
Elekta AB stock logo
EKTAY
Elekta
DowngradeHoldStrong Sell
5/26/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Reiterated RatingOutperform
5/21/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$141.00 ➝ $162.00
4/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Set Price Target$170.00
4/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$135.00 ➝ $140.00
4/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetOverweight$120.00 ➝ $140.00
4/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetOverweight$135.00 ➝ $138.00
4/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$131.00 ➝ $141.00
4/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$127.00 ➝ $136.00
(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elekta AB stock logo
EKTAY
Elekta
$1.78B1.15$0.62 per share9.00$2.19 per share2.54
Glaukos Corporation stock logo
GKOS
Glaukos
$507.44M14.67N/AN/A$11.42 per share11.10
Sartorius stock logo
SARTF
Sartorius
$3.66B2.04N/AN/AN/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$3.32B1.66$0.84 per share10.43$4.92 per share1.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elekta AB stock logo
EKTAY
Elekta
-$55.30M-$0.16N/A11.83N/A-3.32%10.67%3.21%8/27/2026 (Estimated)
Glaukos Corporation stock logo
GKOS
Glaukos
-$187.69M-$3.28N/A269.70N/A-34.34%-6.92%-5.25%7/29/2026 (Estimated)
Sartorius stock logo
SARTF
Sartorius
$90.90M$2.15101.23N/AN/A3.82%8.19%3.15%7/23/2026 (Estimated)
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$235.54M$0.3823.0015.07N/A7.13%7.23%5.20%8/5/2026 (Estimated)

Latest EKTAY, SARTF, GKOS, and SSMXY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2026Q4 2026
Elekta AB stock logo
EKTAY
Elekta
N/A$0.06N/A-$0.25N/A$521.00 million
5/14/2026Q4 2026
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$0.0374$0.02-$0.0174$0.02$862.45 million$877.92 million
4/29/2026Q1 2026
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.30-$0.18+$0.12-$0.34$137.00 million$150.57 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Elekta AB stock logo
EKTAY
Elekta
$0.132.34%N/AN/A N/A
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
Sartorius stock logo
SARTF
Sartorius
N/AN/AN/AN/AN/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$0.070.80%N/A18.42%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elekta AB stock logo
EKTAY
Elekta
0.56
0.95
0.73
Glaukos Corporation stock logo
GKOS
Glaukos
0.10
5.43
4.73
Sartorius stock logo
SARTF
Sartorius
0.89
0.95
0.49
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
0.12
3.26
2.44

Institutional Ownership

CompanyInstitutional Ownership
Elekta AB stock logo
EKTAY
Elekta
N/A
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
Sartorius stock logo
SARTF
Sartorius
N/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
N/A

Insider Ownership

CompanyInsider Ownership
Elekta AB stock logo
EKTAY
Elekta
41.28%
Glaukos Corporation stock logo
GKOS
Glaukos
5.90%
Sartorius stock logo
SARTF
Sartorius
N/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Elekta AB stock logo
EKTAY
Elekta
4,556368.59 million216.44 millionNot Optionable
Glaukos Corporation stock logo
GKOS
Glaukos
1,09458.73 million55.27 millionOptionable
Sartorius stock logo
SARTF
Sartorius
13,52834.23 millionN/ANot Optionable
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
11,457629.48 millionN/ANot Optionable

Recent News About These Companies

Sysmex Corp Stock Price History
SSMXY Share News Today
MP: Mohan woos Sysmex, Panasonic Energy to set up facility in MP
Harding Loevner International Equity ADR Q3 2024 Report
NCLTY Nitori Holdings Co., Ltd.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Elekta stock logo

Elekta OTCMKTS:EKTAY

$5.56 +0.05 (+0.91%)
As of 02:22 PM Eastern

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Glaukos stock logo

Glaukos NYSE:GKOS

$126.76 +2.50 (+2.01%)
Closing price 03:59 PM Eastern
Extended Trading
$126.86 +0.10 (+0.08%)
As of 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Sartorius stock logo

Sartorius OTCMKTS:SARTF

$217.65 0.00 (0.00%)
As of 06/11/2026

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Sysmex stock logo

Sysmex OTCMKTS:SSMXY

$8.74 -0.24 (-2.67%)
As of 03:52 PM Eastern

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.